EUVIMEDEUVIMED entdecken
Crossref

Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens

Layaly Shkair, Diksha Sharma, Shaimaa Hamza, Ekaterina Garanina, Venara Shakirova, Ilsiyar Khaertynova, Maria Markelova, Vera Pavelkina, Albert Rizvanov, Svetlana Khaiboullina, Manoj Baranwal, Ekaterina Martynova iD

Biotechnology and Applied Biochemistry · 2024-10 · 71 (5) · 1139-1153

DOI: 10.1002/bab.2604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 23.05.2024. Verfasst von Layaly Shkair und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia. Hauptthemen laut MEDLINE: Cross Reactions, Antigens, Viral, Antibodies, Viral, Puumala virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: RSF-DST, DST/INT/RUS/RSF/P-51/2021.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephropathia epidemica (NE), caused by Puumala (PUUV) orthohantavirus, is endemic in the Republic of Tatarstan (RT). There are limited options for NE prevention in RT. Currently, available vaccines are made using Haantan (HNTV) orthohantavirus antigens. In this study, the efficacy of microvesicles (MVs) loaded with PUUV antigens to induce the humoral immune response in small mammals was analyzed. Additionally, the cross‐reactivity of serum from immunized small mammals and NE patients with HNTV, Dobrava, and Andes orthohantaviruses was investigated using nucleocapsid (N) protein peptide libraries. Finally, the selected peptides were analyzed for allergenicity, their ability to induce an autoimmune response, and their interaction with Class II HLA. Several N protein peptides were found to be cross‐reactive with serum from MVs immunized small mammals. These cross‐reactive epitopes were located in oligomerization perinuclear targeting and Daxx‐interacting domains. Most cross‐reactive peptides lack allergenic and autoimmune reactivity. Molecular docking revealed two cross‐reacting peptides, N6 and N19, to have good binding with three Class II HLA alleles. These peptides could be candidates for developing vaccines and therapeutics for NE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross ReactionsAntigens, ViralAntibodies, ViralPuumala virusAnimalsHumansImmunizationMolecular Docking SimulationOrthohantavirus

Stichwörter der Autor:innen

PUUVantibodieshantavirus

Substanzen

Antigens, ViralAntibodies, Viral

Autor:innen und Institutionen

  • Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
  • Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, India.
  • Department of Infectious Diseases, Kazan State Medical Academy, Kazan, Russia.
  • Infectious Diseases Department, National Research Ogarev Mordovia State University, Saransk, Russia.

ORCID-Profile: Ekaterina Martynova

Förderung

  • RSF-DST
  • DST/INT/RUS/RSF/P-51/2021

Zitieren

APA

Shkair, L., Sharma, D., Hamza, S., Garanina, E., Shakirova, V., Khaertynova, I., Markelova, M., Pavelkina, V., Rizvanov, A., Khaiboullina, S., Baranwal, M., & Martynova, E. (2024). Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens. Biotechnology and Applied Biochemistry, 71(5), 1139-1153. https://doi.org/10.1002/bab.2604

Vancouver

Shkair L, Sharma D, Hamza S, Garanina E, Shakirova V, Khaertynova I, et al. Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens. Biotechnology and Applied Biochemistry. 2024;71(5):1139-1153. doi:10.1002/bab.2604

BibTeX
@article{Shkair2024,
  author = {Shkair, Layaly and Sharma, Diksha and Hamza, Shaimaa and Garanina, Ekaterina and Shakirova, Venara and Khaertynova, Ilsiyar and Markelova, Maria and Pavelkina, Vera and Rizvanov, Albert and Khaiboullina, Svetlana and Baranwal, Manoj and Martynova, Ekaterina},
  title = {Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  volume = {71},
  number = {5},
  pages = {1139--1153},
  doi = {10.1002/bab.2604}
}
Kostenlos starten →